Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Kataka: Odisha’s Sushree Dibyadarshini has been named in the India A squad for the multi-day match against Australia A during...
Bhubaneswar: The India Meteorological Department (IMD) has issued a nowcast warning for seven districts of Odisha, including twin cities of...
Chennai: Odisha’s Rutaparna and Swetaparna Panda were at their best in the Yonex-Sunrise All India Senior Ranking Badminton tournament in...
Cuttack: Odisha cricketer Sushree Dibyadarshini has been selected by the All-India Women’s Selection Committee to participate in the Targeted Women’s...
Copyright © 2026 Frontier Media
